To furnish immediate evidence the peculiar improvement of catecholaminergic activity during the brain in animals treated with a small dose of (?)deprenyl is unrelated to MAO inhibition, we created in the early '90s a family members of deprenyl analogues devoid with the MAO-B inhibitory effect (Knoll et alBy means of PPAP, suppliers and consumers co